Charting roadmaps towards novel and safe synergistic immunotherapy combinations
ISSN: 2662-1347
Année de publication: 2022
Volumen: 3
Número: 6
Pages: 665-680
Type: Révision
ISSN: 2662-1347
Année de publication: 2022
Volumen: 3
Número: 6
Pages: 665-680
Type: Révision